FDA Drug Safety Communication: FDA warns of next-day impairment with sleep aid Lunesta (eszopiclone) and lowers recommended dose

<!–

–>

<!–

• Page Last Updated: 05/29/2014

–>
Page Last Updated: 05/29/2014
<!–

–>

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.